2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1902207459 MD
Verify on CMS →

CARLOS VIVES ALVARADO, MD

Glaucoma Specialist (Ophthalmology) Physician in RIO PIEDRAS, Puerto Rico. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
6K
Medicare Part D claims · 885 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
52%
generic claims · 48% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$589.69
13 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

CARLOS VIVES ALVARADO, MD filed 5,585 Medicare Part D claims in 2023 as a Glaucoma Specialist (Ophthalmology) Physician in RIO PIEDRAS, Puerto Rico, prescribing 52% generic.

6K
Part D claims, 2023
52%
generic prescribing
$589.69
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

CARLOS VIVES ALVARADO, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

5,585 Top 5% higher than 95% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

CARLOS VIVES ALVARADO, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about CARLOS VIVES ALVARADO, MD?

Quality data not reported

NPI registry status

Active

Issued 09/15/2014

NPI 1902207459

Primary specialty

Glaucoma Specialist (Ophthalmology) Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

5,585 89% vs specialty avg

2023 prescription claims

Specialty avg: 2,962

Specialty distribution in Puerto Rico

How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among Puerto Rico providers

Puerto Rico providers

Glaucoma Specialist (Ophthalmology) Physician share within Puerto Rico

1. Glaucoma Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Glaucoma Specialist (Ophthalmology) Physician share within Puerto Rico

Specialty board-certification context

Estimated specialty board-certified rate — Glaucoma Specialist (Ophthalmology) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Glaucoma Specialist (Ophthalmology) Physician ABMS/AOA estimate

Est. board-certified rate (Glaucoma Specialist (Ophthalmology) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Glaucoma Specialist (Ophthalmology) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CARLOS VIVES ALVARADO, MD appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding MD credentials at AVE. DE DIEGO 369, RIO PIEDRAS, PR, 00923, with a listed phone of (787) 767-8872. NPI 1902207459 was issued on 09/15/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what VIVES ALVARADO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 5,585 prescription claims written by this provider, covering 885 Medicare beneficiaries and totaling roughly $558K in drug spend, split 48% brand-name and 52% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

AVE. DE DIEGO 369
RIO PIEDRAS, PR 00923

Provider Details

NPI 1902207459
Specialty Glaucoma Specialist (Ophthalmology) Physician
Credentials MD
Gender Male
NPI Issued 09/15/2014

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CARLOS VIVES ALVARADO, MD. Source: openpaymentsdata.cms.gov.

Total received

$590

Largest payer

Bausch & Lomb Americas Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

CARLOS VIVES ALVARADO, MD — brand share 48.0%
Specialty average (est.)

48% brand-name claims vs 52% generic, on 5,585 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

5,585
Total Claims
$558K
Total Drug Cost
885
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
6,865
Total Day Supply
183,261
Brand vs Generic
48% brand / 52% generic
Brand Drug Cost
$468K
Generic Drug Cost
$90K

Patient Demographics

Average Patient Age
75.1 years
Avg HCC Risk Score
1.72
Gender Split
59% female / 41% male
Age Distribution
<65: 52, 65-74: 377, 75-84: 344, 85+: 112

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What CARLOS VIVES ALVARADO, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
898
Lumigan
Bimatoprost
772
Prednisolone Acetate
504
Ketorolac Tromethamine
343
Ofloxacin
328
Dorzolamide Hcl
324
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
318
Fluorometholone
294
Brimonidine Tartrate
276
Timolol Maleate
229

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Glaucoma Specialist (Ophthalmology) Physician Overview

How CARLOS VIVES ALVARADO, MD fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.

354
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider

CARLOS VIVES ALVARADO, MD's 5,585 claims are above the specialty average of 2,962.

Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in Puerto Rico

Other clinicians with the same primary specialty enrolled in Puerto Rico, drawn from the same CMS NPPES roster as VIVES ALVARADO.

Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is CARLOS VIVES ALVARADO, MD's specialty?
CARLOS VIVES ALVARADO, MD specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in RIO PIEDRAS, Puerto Rico. Credentials: MD.
How much does CARLOS VIVES ALVARADO, MD prescribe under Medicare Part D?
In 2023, CARLOS VIVES ALVARADO, MD wrote 5,585 Medicare Part D claims totaling $558K in drug costs for 885 beneficiaries.
Where is CARLOS VIVES ALVARADO, MD located?
CARLOS VIVES ALVARADO, MD is located at AVE. DE DIEGO 369, RIO PIEDRAS, PR, 00923. Phone: (787) 767-8872.
What is CARLOS VIVES ALVARADO, MD's NPI number?
CARLOS VIVES ALVARADO, MD's National Provider Identifier (NPI) is 1902207459, issued on 09/15/2014.
Does CARLOS VIVES ALVARADO, MD prescribe more brand-name or generic drugs?
CARLOS VIVES ALVARADO, MD's prescribing is 48% brand-name and 52% generic drugs by claim count, with $468K in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US?
There are 354 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does CARLOS VIVES ALVARADO, MD prescribe most often?
Based on 2023 Medicare Part D data, CARLOS VIVES ALVARADO, MD's most frequently prescribed drugs include Latanoprost, Lumigan, Prednisolone Acetate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CARLOS VIVES ALVARADO, MD accept Medicare?
CARLOS VIVES ALVARADO, MD appears in CMS Medicare data with 5,585 Part D claims and 885 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CARLOS VIVES ALVARADO, MD's credentials?
CARLOS VIVES ALVARADO, MD's NPI is 1902207459 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology